Newsmax (NMAX) debuted on the New York Stock Exchange on Monday, selling 7.5 million Class B shares at $10 apiece.
Shares surged 550% as intraday trading volume catapulted to over 4.68 million.
Corcept Therapeutics (CORT) shares soared 87% after the company said its phase 3 trial of relacorilant plus nab-paclitaxel to treat a type of ovarian cancer met its primary goal.
Piper Sandler raised Corcept's price target to $128 from $78 while maintaining its overweight rating.
More than 9.33 million shares of Corcept traded intraday compared with a daily average of about 1.01 million.
Newton Golf (NWTG) reported a year-over-year increase Monday of 817% in its Q4 net sales.
Shares advanced 35%, with intraday trading volume rising to over 47.5 million compared with a daily average of more than 1.16 million.
Price: 66.12, Change: +56.12, Percent Change: +561.24
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。